The MAHA Movement Loves Psychedelics. Should Wall Street?

wsj.com/health/pharma/psychedelic-drugs-investment-maha-f4b7dff0

A nasal spray for treatment-resistant depression has delivered strong clinical results and rekindled investor hopes.

This story appeared on wsj.com, 2025-07-06 09:30:00.
The Entire Business World on a Single Page. Free to Use →